Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Hearing aids OK’d for over-the-counter sale starting in October, prices expected to fall

The Food and Drug Administration said the new regulation creates a new class of hearing aids that don’t require a medical exam or prescription. They’ll be sold online or over-the-counter at pharmacies and other stores.

Chicago Sun-Times

Covid vaccine plan for the very young

The government plans to buy 2.9 million doses of Covid-19 vaccine from Pfizer for children aged from six months to four years.

Bangkok Post

This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

What's behind the FDA's controversial strategy for evaluating new COVID boosters

Some scientists are alarmed that the agency plans to evaluate the next generation of boosters by reviewing mouse studies alone. Others say there's no time to waste waiting for human trials.

WEKU

Hearing aids will now be available without a hearing test. Here’s what to know about the new rule

Adults with mild to moderate hearing loss will now be able to buy hearing aids without getting their hearing tested by an audiologist or other specialist, under a new FDA rule announced Tuesday.

The Philadelphia Inquirer

'Stoner Patch' Or 'Sour Patch Kids'? Hard To Tell, British Police Launched A Raid To Find Out

The Police in the UK recently seized almost 150 separate items, including cannabis edibles, marijuana resin, more than 5kg of cannabis flowers, and nearly £5,000 in cash.

Benzinga

If You Invested $1,000 In Johnson & Johnson Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has approved Bluebird bio’s (NASDAQ:BLUE) lead asset ZYNTEGLO (betibeglogene autotemcel) to treat the underlying genetic cause of beta‑thalassemia in adult and pediatric patients who require regular red blood cell (RBC) transfusions. Bluebird shares traded in a range of $6.13 to $8.18 on a day…

Benzinga

What We Know About the FBI's Latest National 'Human Trafficking' Sting

Plus: Book ban enthusiasm ensnares Bible, free speech for nutrition advice, and more...

Reason

NOVN: EPI Revenue Trends Are Strong

By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT

Benzinga

Arizona Expands the Right To Try New Medical Treatments

It’s a small step toward breaking down barriers between patients and innovative medicine.

Reason

This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday

Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids.

Benzinga

Millions of Americans will soon be able to buy hearing aids without a prescription

A new FDA rule allows adults with perceived mild to moderate hearing loss to buy hearing aids over the counter. Efforts to make them more affordable and accessible have been in the works for years.

WEKU

FDA finalizes over-the-counter hearing aid rule

WASHINGTON — The Food and Drug Administration on Tuesday finalized a rule making hearing aids for people with mild to moderate hearing loss available without requiring them to see a doctor.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

5 Income Stocks to Turn to When Times Are Tough

The S&P 500 is coming off its four-week win streak amid signals of cooling price increases. However, inflation is still running hot near a 40-year high, which might induce the Fed to continue its policy rate hikes. We think income stocks AbbVie (ABBV), Amgen (AMGN), Pfizer (PFE), Bristol-Myers Squibb (BMY),…

The Conversation

Wellness vapes: what you need to know about vaping vitamins and other supplements

So-called wellness vapes are growing in popularity. Unlike regular vapes (e-cigarettes) that contain nicotine, these products contain vitamins, hormones or essential oils. But they have caught the attention of the US Food and Drug Administration (FDA) because of the unproven health claims made by many of the companies that sell…

The Independent UK

Powerful reactions pour in as FDA clears way for hearing aids to be available over the counter

Close to 30 million adults in the US could stand to benefit from hearing aid use

Axios

Coming soon: Over-the-counter hearing aids

People with hearing loss will soon be able to buy hearing aids without needing to have an exam, prescription or special fitting first.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Over-the-counter hearing aids expected this fall in US

U.S. regulators have finalized a long-awaited rule that's expected to allow millions of Americans to buy hearing aids without a prescription

Roll Call

FDA finalizes over-the-counter hearing aid rule - Roll Call

The FDA finalized a long-awaited rule allowing people with mild to moderate hearing loss to buy a hearing aid without first seeing a doctor.

WEKU

The U.K. approved omicron-specific booster shots. They're coming to the U.S. soon

In the U.S., officials have asked vaccine makers to target BA.5, rather than the original omicron strain. That has delayed the boosters' development — but officials hope they will be more effective.

The Independent UK

Government plan to cut civil servants’ redundancy pay ‘add insult to injury’, says union

Ministers want ‘job cuts on the cheap’, says PCS union – as Rishi Sunak attacks ‘bloated’ state

Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

Gritstone bio (NASDAQ:GRTS) announced that interim results from the Phase 1/2 trial of GRANITE, its individualized, vaccine-based immunotherapy candidate for solid tumor cancers, were published today in Nature Medicine. The initial results from the study are expected during second half of 2023. Gritstone shares traded in a range of $3.96 to $4.24…

The Independent UK

Sunak commits to Civil Service cuts as part of plan for Whitehall ‘shake-up’

The former chancellor said the ‘bloated post-Covid state is in need of a shake-up’.

Bangkok Post

No Häagen-Dazs recall in Thailand - FDA

Certain batches of Häagen-Dazs ice cream products that have been found to be contaminated with traces of a chemical linked to cancer have not been imported into Thailand, Food and Drug Administration (FDA) deputy secretary-general Weerachai Nolwachai said on Saturday.

1 … 175 176 177 178

People

Taweesilp Visanuyothin

30 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.